Samsung Medical Center
Ankylosing spondylitis treatment cost in the Republic of Korea typically involves specialized imaging like a spine X-ray, which ranges from Price on request to Price on request , and ongoing physiotherapy running from $100 to $300 per session. Expenses depend on the disease stage and the need for biologic therapies. Patients can expect 30-50% savings compared to the US. Most advanced care is centered in Seoul, Busan, and Incheon.
Typical Ankylosing Spondylitis Treatment Costs in Republic of Korea
Bookimed Expert Insight: Multidisciplinary care is essential for managing systemic inflammation and mobility. Seoul National University Bundang Hospital (SNUBH) is ideal for complex diagnostics. It utilizes the BESTcare system to minimize medical errors during long-term treatment. For patients focused on specialized musculoskeletal recovery, Kang Dong Hospital in Busan offers a world-renowned multi-pronged orthopedic approach. Large centers like Severance Hospital provide JCI-accredited safety standards for international patients.
| Republic of Korea | Turkey | Austria | |
| Physiotherapy | from $100 | from $50 | from $600 |
| Stem cell therapy for ankylosing spondylitis | - | from $7,000 | from $20,000 |
| Biological therapy | - | from $5,500 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Ankylosing spondylitis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ankylosing spondylitis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ankylosing spondylitis treatment journey.
Dr. Yang Yeongjun is an orthopedic surgeon focused on joint care and arthroscopy. He treats knee and shoulder disorders and performs arthroscopic surgery and joint replacement (arthroplasty). He also manages trauma and sports conditions, including sports injuries, foot and ankle problems, carpal tunnel syndrome, and fractures.
He completed his orthopedic surgery residency at Catholic Medical Center. He then completed a fellowship at Catholic Medical Center St. Paul’s Hospital. He is a full member of the Korean Arthroscopy Society, the Korean Knee Society, and the Korean Shoulder and Elbow Society.
Dr. Jang Hyo Kim is an orthopedic surgeon at Leadheal Hospital in Seoul. He specializes in joint preservation and complex reconstruction. He completed a fellowship in Ilizarov external fixation surgery in Russia. Dr. Kim currently serves as the Joint Center Director at Very Good Hospital. He is an adjunct professor at Kyung Hee University.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
Dr. Chul-Won Ha is an orthopedic and joint replacement surgeon at Samsung Medical Center in Seoul. He specializes in knee and hip injuries, bone tumors, and complex fractures. Dr. Ha earned both his M.D. and Ph.D. from Seoul National University. He performs procedures at a clinic ranked as a World’s Best Smart Hospital by Newsweek.
South Korea National Health Insurance covers biologics for ankylosing spondylitis under the Rare Intractable Disease program. Patients typically pay only 10% of treatment costs. Coverage requires specific clinical criteria like active sacroiliitis on imaging and failure of conventional therapies after 3 months.
Bookimed Expert Insight: Patients should prioritize university hospitals like Severance or Asan Medical Center for initial biologic approval. These academic centers manage high patient volumes and have streamlined systems for RID registration. Major facilities also utilize digital systems like BESTcare to track treatment history and prevent documentation errors during appeals.
Patient Consensus: Patients note that documenting every medication failure is vital for insurance approval. Many find that while initial drug costs seem high, the 10% co-pay cap makes long-term biologic therapy affordable.